Dronedarone in patients with congestive heart failure: insights from ATHENA
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.
Originalsprog | Engelsk |
---|---|
Tidsskrift | European Heart Journal |
Vol/bind | 31 |
Udgave nummer | 14 |
Sider (fra-til) | 1717-21 |
Antal sider | 5 |
ISSN | 0195-668X |
DOI | |
Status | Udgivet - 1 jul. 2010 |
ID: 34116064